Heska Corporation

Heska Corporation

Heska Corporation operates as a publicly traded company (symbol: HSKA) focused on veterinary diagnostic technology. Public records indicate the company designs and manufactures in-clinic blood analyzers, digital radiography systems, and cloud-based data management platforms for veterinary clinics. The firm's primary revenue comes from consumables and recurring service contracts tied to its installed base of analyzers, which is a model more like a medical device manufacturer than a conventional asset manager. The company's strategy centers on vertical integration: Heska owns its R&D, manufacturing, and sales channels across North America and parts of Europe. Asset-class mix is not applicable here, as the firm does not manage third-party capital. The geographic footprint includes operations in the United States and limited distribution in Europe and Asia. Named portfolio companies are not applicable, as Heska is itself an operating company rather than an investment entity. As of its 2022 annual filing, Heska reported approximately $263 million in revenue. The company maintained a sales force of several hundred employees across its Loveland headquarters and field offices. No additional offices are confirmed beyond Loveland. There is no associated philanthropic structure. Heska's structural differentiator is its position as a publicly traded operating company in the veterinary space, which means its primary fiduciary duty is to public shareholders rather than to a family or foundation. This governance model sets it apart from private family offices or fund managers that might invest in similar industries. Succession and governance are determined by the company's board and shareholders, not by an individual family or principal.